Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial

BACKGROUND: Polypharmacy is common in heart failure (HF), whereas its effect on adverse outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. AIM: To evaluate the prevalence, prognostic impacts, and predictors of polypharmacy in HFpEF patients. DESIGN AND SETTING: A retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuzhong, Zhu, Wengen, He, Xin, Xue, Ruicong, Liang, Weihao, Wei, Fangfei, Wu, Zexuan, Zhou, Yuanyuan, Wu, Dexi, He, Jiangui, Dong, Yugang, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716870/
https://www.ncbi.nlm.nih.gov/pubmed/33257457
http://dx.doi.org/10.3399/bjgp21X714245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716870/
https://www.ncbi.nlm.nih.gov/pubmed/33257457
http://dx.doi.org/10.3399/bjgp21X714245

Ejemplares similares